ProfileGDS4718 / 208716_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 98% 98% 95% 99% 99% 97% 96% 98% 99% 99% 99% 99% 94% 97% 97% 98% 99% 98% 96% 95% 99% 99% 99% 99% 98% 98% 99% 96% 98% 97% 98% 97% 98% 99% 98% 97% 98% 98% 99% 94% 98% 97% 97% 96% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.736498
GSM549102patient 115, normal, homogenized [OPG study]11.415698
GSM549104patient 119, normal, homogenized [OPG study]10.357895
GSM549108patient 138, normal, homogenized [OPG study]12.262899
GSM549119patient 077, normal, homogenized [OPG study]12.538399
GSM549133patient 032, cancer, homogenized [OPG study]11.137697
GSM549139patient 042, cancer, homogenized [OPG study]10.557596
GSM549099patient 107, normal, homogenized [OPG study]11.810698
GSM549109patient 139, normal, homogenized [OPG study]12.416199
GSM549110patient 046, normal, homogenized [OPG study]12.249599
GSM549114patient 063, normal, homogenized [OPG study]12.101199
GSM549122patient 082, normal, homogenized [OPG study]12.487899
GSM549134patient 033, cancer, homogenized [OPG study]10.041594
GSM549136patient 036, cancer, homogenized [OPG study]11.029897
GSM549140patient 044, cancer, homogenized [OPG study]10.976897
GSM549111patient 047, normal, homogenized [OPG study]11.691598
GSM549113patient 057, normal, homogenized [OPG study]12.398999
GSM549132patient 031, cancer, homogenized [OPG study]11.054898
GSM549137patient 038, cancer, homogenized [OPG study]10.425596
GSM549142patient 047, cancer, homogenized [OPG study]9.6764395
GSM549100patient 110, normal, homogenized [OPG study]12.206899
GSM549107patient 135, normal, homogenized [OPG study]12.384699
GSM549115patient 068, normal, homogenized [OPG study]12.370999
GSM549116patient 072, normal, homogenized [OPG study]12.555799
GSM549120patient 078, normal, homogenized [OPG study]11.832298
GSM549131patient 030, cancer, homogenized [OPG study]11.343298
GSM549118patient 074, normal, homogenized [OPG study]12.579699
GSM549129patient 027, cancer, homogenized [OPG study]10.342596
GSM549123patient 088, normal, homogenized [OPG study]11.843498
GSM549124patient 006, cancer, homogenized [OPG study]10.818297
GSM549126patient 015, cancer, homogenized [OPG study]11.032698
GSM549128patient 025, cancer, homogenized [OPG study]10.912197
GSM549103patient 117, normal, homogenized [OPG study]11.687298
GSM549117patient 073, normal, homogenized [OPG study]12.097599
GSM549138patient 041, cancer, homogenized [OPG study]11.311298
GSM549141patient 045, cancer, homogenized [OPG study]11.108497
GSM549130patient 028, cancer, homogenized [OPG study]11.060998
GSM549101patient 111, normal, homogenized [OPG study]11.552198
GSM549105patient 128, normal, homogenized [OPG study]12.158599
GSM549106patient 134, normal, homogenized [OPG study]10.210894
GSM549112patient 048, normal, homogenized [OPG study]11.928798
GSM549125patient 011, cancer, homogenized [OPG study]10.694997
GSM549127patient 024, cancer, homogenized [OPG study]10.627797
GSM549135patient 035, cancer, homogenized [OPG study]10.578196